Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
University of Alberta Medical School, Edmonton, AB, Canada.
Can J Anaesth. 2020 Nov;67(11):1595-1623. doi: 10.1007/s12630-020-01791-5. Epub 2020 Aug 18.
Renal damage secondary to fluoride ions and compound A (CpdA) after sevoflurane anesthesia remains unclear. For safety reasons, some countries still recommend minimum fresh-gas flows (FGFs) with sevoflurane. We review the evidence regarding the intraoperative use of sevoflurane for anesthesia maintenance and postoperative renal function compared with other anesthetic agents used for anesthetic maintenance. Secondarily, we examine the effects of peak plasma fluoride and CpdA levels and the effect of FGF and duration of anesthesia on these parameters.
The databases of MEDLINE (OVID and Pubmed), EMBASE, the Cochrane Library, Health Technology Assessment Database, CINAHL, and Web of Science were searched from inception until 23 April 2020 to identify randomized-controlled trials (RCTs) in humans utilizing sevoflurane or an alternative anesthetic for anesthesia maintenance with subsequent measurements of renal function. Two different paired reviewers independently selected the studies and extracted data. The quality of the evidence was appraised using GRADE recommendations.
Of 3,766 publications screened, 41 RCTs in human patients were identified. There was no difference between creatinine at 24 hr (21 studies; n = 1,529), or creatinine clearance (CCR) at 24 hr (12 studies; n = 728) in the sevoflurane vs alternative anesthetic groups. Peak fluoride and fluoride measured at 24 hr were higher with sevoflurane compared with other inhaled anesthetics. Subgroup analyses for sevoflurane usage in various contexts showed no significant difference between sevoflurane and alternative anesthetics for creatinine or CCR at 24 hr at varying FGF, duration of exposure, baseline renal function, or absorbent use.
We did not find any association between the use of sevoflurane and postoperative renal impairment compared with other agents used for anesthesia maintenance. The scientific basis for recommending higher FGF with the use of sevoflurane needs to be revisited.
氟离子和复合物 A(CpdA)继发于七氟醚麻醉的肾损伤仍不清楚。出于安全原因,一些国家仍建议七氟醚最小新鲜气流(FGF)。我们回顾了关于术中使用七氟醚维持麻醉与其他用于维持麻醉的麻醉剂相比对术后肾功能的证据。其次,我们检查了氟化物和 CpdA 峰值血浆水平以及 FGF 和麻醉持续时间对这些参数的影响。
从 1946 年 1 月到 2020 年 4 月 23 日,我们在 MEDLINE(OVID 和 Pubmed)、EMBASE、Cochrane 图书馆、卫生技术评估数据库、CINAHL 和 Web of Science 数据库中搜索了关于人类使用七氟醚或替代麻醉剂维持麻醉后测量肾功能的随机对照试验(RCT)。两名不同的配对审查员独立选择研究并提取数据。使用 GRADE 建议评估证据质量。
在筛选出的 3766 篇论文中,共确定了 41 项人类患者的 RCT。与替代麻醉剂相比,氟化物在 24 小时(21 项研究;n=1529)或氟化物清除率(CCR)在 24 小时(12 项研究;n=728)时,肌酐没有差异。与其他吸入性麻醉剂相比,氟化物和 24 小时时氟化物的峰值更高。七氟醚在不同情况下使用的亚组分析显示,在不同的 FGF、暴露时间、基线肾功能或吸收剂使用情况下,24 小时时肌酐或 CCR 与替代麻醉剂相比,七氟醚与其他麻醉剂之间无显著差异。
与其他用于维持麻醉的药物相比,我们没有发现使用七氟醚与术后肾功能损害之间存在任何关联。需要重新审视推荐使用七氟醚时使用更高的 FGF 的科学依据。